Ethical implications of array comparative genomic hybridization in complex phenotypes: points to consider in research

Area of Science:

• Clinical Genetics and Genomics
• Bioethics and Research Ethics

Background:

• Array comparative genome hybridization (ACGH) is a rapidly emerging diagnostic technology in clinical genetics.
• The clinical significance of phenomena observed with ACGH is not always well understood, raising ethical issues.
• Ethical implications extend to the research process, including study design, data presentation, and interpretation, particularly for complex traits.

Purpose of the Study:

• To examine the ethical considerations surrounding the use of ACGH in research, specifically for complex phenotypes.
• To identify key points for researchers, clinicians, and patients/families to ensure ethical practices in ACGH studies.
• To promote responsible design, presentation, and interpretation of ACGH research, using autism as a case study.

Main Methods:

• Review of recent publications applying ACGH to complex phenotypes, with a focus on autism spectrum disorder.
• Analysis of ethical issues related to the conduct and reporting of ACGH research.
• Identification of best practices for ethical engagement with researchers, clinicians, and patient families.

Main Results:

• ACGH application to complex traits like autism highlights the need for careful ethical deliberation.
• Specific ethical challenges arise in the interpretation and communication of findings from ACGH studies.
• A framework for responsible research conduct is needed to guide the ethical use of ACGH.

Conclusions:

• Ethical considerations are paramount in the research and development of ACGH technologies.
• Responsible stewardship of ACGH research requires attention to study design, data interpretation, and communication.
• Collaboration among researchers, clinicians, and ethics communities is essential for navigating the ethical landscape of ACGH.